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Background: IgG4 production is regulated by type 2 (IL-4 and IL-13) and regulatory (IL-10) cytokines
involved in the pathophysiology of chronic rhinosinusitis (CRS). We sought to determine the patho-
physiological characteristics of IgG4-positive cells in sinonasal tissues in CRS, especially eosinophilic CRS
(ECRS).
Methods: IgG4-positive cells in uncinate tissues (UT) and nasal polyps (NP) were examined by immu-
nohistochemistry. Associations between the number of IgG4-positive cells and clinicopathological factors
were analyzed. Receiver operating characteristics (ROC) analysis was performed to determine the cut-off
value of IgG4-positive cells in tissue that can predict the post-operative course.
Results: IgG4 was mainly expressed in infiltrating plasma and plasmacytoid cells, and the number of
IgG4-positive cells was significantly higher in NP, especially those from severe ECRS patients, than in UT.
In CRS patients, the number of IgG4-positive cells significantly and positively correlated with blood and
tissue eosinophilia, radiological severity, and serum level of total IgE. The number of infiltrating IgG4-
positive cells was significantly higher in patients with a poor post-operative course (sustained sinus
shadow 6 months after surgery) than in those with a good one. The number of IgG4-positive cells in NP
could discriminate patients with a good or a poor post-operative course (area under the curve: 0.769).
Also, 73.3% sensitivity and 82.5% specificity were achieved when the cut-off value was set at 17 cells/
high-power field.
Conclusions: Our results suggest that the local expression of IgG4 on cells may be used as a biomarker
that reflects the pathophysiology of CRS, including the post-operative course.
Copyright © 2018, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ryngology, International Uni-
icine, 4-3 Kozunomori, Narita
ety of Allergology.
rgology. Production and hosting by ElseIntroduction
Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP),
especially eosinophilic chronic rhinosinusitis (ECRS), is one of the
phenotypes of CRS known as an intractable upper airwayvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
T. Koyama et al. / Allergology International 68 (2019) 216e224 217inflammatory disease.1 Although the precise etiology and patho-
physiology underlying this disease remain poorly understood,
altered humoral immunity, including IgG, IgA, and IgE, appears to
be involved.2e4 For example, nasal polyps (NP) contain significantly
higher amounts of IgG and IgA, especially antinuclear antibodies,
than control nasal tissues.4
IgG4 is the least abundant IgG subclass in human serum,
comprising approximately 5% of the total IgG.5 In general, IgG4 is
regarded as an anti-inflammatory antibody because of the lack of
complement activation, inability to undergo antigen cross-linking
due to Fab-arm exchange, and high affinity for inhibitory
FcgRIIb.5,6 It also inhibits the activity of IgE.6,7 Similar to IgE, which
is known to be involved in the pathogenesis of ECRS, type 2 cyto-
kines, including IL-4 and IL-13, and a co-stimulatory signal through
CD40/CD40L are crucial for IgG4 production.2,3,6 In addition, IL-10,
which also plays a substantial role in the pathogenesis of ECRS,
enhances the production of IgG4.6,8,9 An important feature of IgG4
production is its association with chronic high-dose antigen
exposure.6 For example, chronic exposure to cat allergen induces
IgG4 production, especially in patients with cat allergy.10
CRS is known to accompany IgG4-related disease (IgG4-RD) in
9.2%e51.9% of patients.11e13 IgG4-RD is a recently established sys-
temic disorder characterized by mass-forming lesions in mainly
exocrine tissues, such as the pancreas, lacrimal glands, and sub-
mandibular glands, consisting of fibrosclerosis and lympho-
plasmacytic infiltration, especially numerous IgG4-positive plasma
cells.14 Although the precise pathogenesis of IgG4-RD remains un-
clear, type 2 cytokines, including IL-4 and IL-13, and regulatory
cytokines, including IL-10 and TGF-b produced by mast cells, are
known to play a substantial role.15,16 On the other hand, little is
known on whether IgG4 or IgG4-positive cells play a role in the
pathogenesis of CRS, including ECRS, regardless of IgG4-RD. NP
contained significantly increased levels of IgG4 compared with
uncinate process tissues (UT) fromnot only healthy control subjects
but also patients with CRSsNP.17 A recent report showed that the
number of IgG4-positive plasma cells is increased in nasal mucosal
specimens in CRS, and that hyperplasia of the nasal glands was
observed significantly more frequently in patients with high IgG4
expression than in those with low IgG4 expression.18
In the present study, we sought to determine the pathophysi-
ological characteristics of IgG4-positive cells in sinonasal tissues in
CRS. We found that local IgG4-positive cell infiltration may be a
novel biomarker that not only reflects the severity of CRS, but also
predicts the post-operative course.
Methods
Patients
Seventy-one Japanese patients with CRS (47 males and 24 fe-
males; mean age, 55.8 years) were enrolled. None of all patientsTable 1
Subjects characteristics.
Groups Non-CRS (UT) CRSsNP (UT) No
Number 13 14 27
Age (years old) 61.4 (41e92) 60.5 (35e75) 57
Sex (female/male) 9/4 6/8 8/
Blood eosinophil rate (%) 2.1 (0e5.9) 2.5 (0.8e8.6) 3.
Serum toal IgE (IU/mL) 34.5 (2e99) 141.7 (4e923) 16
FEV1/FVC ratio (%) 83.8 (68.7e92.7) 77.3 (66.5e84.7) 78
CT grading score (LundeMackay) 1.9 (1e3) 6.5 (1e14) 13
Comorbidity of asthma (n) 0 0 5
Comorbidity of NSAIDs intorelance (n) 0 0 2
Data are shown as the mean with ranges in parentheses.met the diagnostic criteria for IgG4-RD.14 Among these, 57 patients
exhibited NP (CRSwNP) and the remainder demonstrated no visible
NP in the middle meatus (CRSsNP; n ¼ 14). Patients with CRSwNP
were divided into non-ECRS (n ¼ 27) and ECRS (n ¼ 30) groups
based on the Japanese Epidemiological Survey of Refractory
Eosinophilic Chronic Rhinosinusitis (JESREC) criteria. In brief, the
JESREC scoring system assesses unilateral or bilateral disease, the
presence of NP, degree of blood eosinophilia, and dominant shadow
of ethmoid sinus in computed tomography (CT) scans. A case was
diagnosed as ECRS if it showed a JESREC score of 11 or more and
tissue eosinophilia of 70 ormore per high-power field (HPF; 400).
The severity of ECRS was further determined by the JESREC algo-
rithm using factor A (presence of both blood eosinophilia equal to
ormore than 5% and an ethmoid-dominant shadowon CT scan) and
factor B (comorbid bronchial asthma or nonsteroidal anti-
inflammatory drug intolerance) as follows: cases negative for
both factors A and B, cases positive for either factor A or B, or cases
positive for both factors A and B were grouped into mild, moderate,
or severe ECRS groups, respectively.1 Using this algorithm, 30 ECRS
patients were divided into the mild (n ¼ 8), moderate (n ¼ 12), and
severe (n ¼ 10) ECRS subgroups. All CRSsNP patients were diag-
nosed as being non-ECRS using this criterion. To eliminate the ef-
fect of medications on the expression of IgG4, patients were
excluded if they received pharmacotherapy for CRS, such as oral
corticosteroids, within 8 weeks prior to surgery, or other medica-
tions, such as macrolide antibiotics and intranasal corticosteroids,
within 3 weeks prior to surgery. During surgery, NP and UT were
taken from patients with CRSwNP and CRSsNP, respectively. Serum
samples were kept from 17 patients (non-ECRS: n ¼ 6, mild ECRS:
n¼ 4, moderate ECRS: n ¼ 2, severe ECRS: n ¼ 5). As the control, 13
non-CRS patients (e.g., patients with blowout fracture, posterior
ethmoidal cyst, or sphenoidal cyst) with normal UT at inspection
were enrolled (4 males and 9 females; mean age, 61.4 years). After
surgery, CRS patients received medications including macrolides
and mucolytic agents for 2 months, together with saline douching
which was continued as long as they could. In addition, NP patients
received systemic corticosteroids (prednisolone: started with
20 mg/day then gradually decreased for 1 month) followed by
intranasal corticosteroids. Furthermore, ECRS patients basically
receive oral antileukotrienes. Informed consent for participation in
the study was obtained from each patient, and the study was
approved by the Human Research Committee of the Okayama
University Graduate School of Medicine and Dentistry (1505-030).
Patients’ characteristics
The clinical characteristics of the patients are presented in
Table 1. Twenty patients were asthmatic and all had NP. Half
(n ¼ 10) of the asthmatic patients were regarded as atopic showing
elevated serum IgE concentration above 170 IU/ml (Pharmacia,
Uppsala, Sweden). Among the asthmatic patients, 5 patients weren-ECRS (NP) Mild ECRS (NP) Moderate ECRS (NP) Severe ECRS (NP)
8 12 10
.6 (36e84) 56.8 (34e70) 52.5 (32e78) 49.5 (33e74)
19 2/6 5/7 3/7
2 (0.1e7.3) 3.8 (2.6e4.7) 5.6 (1.7e7.9) 11.4 (6.9e22.8)
4.6 (4-1322) 150.4 (10e452) 256.4 (34-1768) 476.2 (34-1899)
.3 (47.2e91.9) 76.3 (73.2e86.4) 76.0 (49.2e92.3) 72.8 (52.6e89.5)
.4 (3e24) 14.3 (8e22) 13.4 (7e21) 16.6 (10e24)
0 5 10
0 1 3
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based on their history of asthma attacks precipitated by non-
steroidal anti-inflammatory drugs. Prior to surgery, the serum
level of total IgE, blood eosinophil rate, and 1-s forced expiratory
volume/forced vital capacity (FEV1/FVC) ratio were determined for
each CRS patient. A radiological assessment of the severity of rhi-
nosinusitis in each patient was also performed using the
LundeMackay system.19 Sections from surgically excised UT and NP
were stained with hematoxylin and eosin, and the average number
of eosinophils per HPF was determined.
In CRSwNP patients complaining of a loss of smell, objective
olfactionwas evaluated using identification threshold in orthonasal
T&T olfactometer testing (n ¼ 51) and the latent time in retronasal
intravenous olfactory testing (n ¼ 49).20,21 In order to examine the
objective residual inflammation after surgery, CT examination was
performed 6 months after surgery in 55 of the 57 patients who
agreed to receive the examination. The post-operative course was
defined as goodwhen the post-operative CT scorewas less than half
of the pre-operative score.
Histological examination and immunohistochemistry
Surgical specimens were fixed in 10% formaldehyde and
embedded in paraffin. Serial sections (4 mm) were cut from each
paraffin-embedded tissue block, and several sections were stained
with hematoxylin and eosin, and IgG4 immunostaining.15,16
Immunohistochemistry was performed on paraffin sections using
an automated Bond Max stainer (Leica Biosystems, Melbourne,
Australia) with anti-human IgG4 mAb (HP6025, 1:400; The Binding
Site, Birmingham, UK) as the primary antibody. The number of
IgG4-positive cells was estimated for areas with the highest density
of positive cells. Three different HPFs (  10 eyepiece and  40
objective lenses) in each section were counted by a pathology
reviewer (YG) blinded to the patients’ characteristics such as JES-
REC criteria, and the average number of positive cells per HPF was
determined; eosinophil numbers were counted as well. Double
immunohistochemistry using anti-human IgG4 mAb and anti-
human CD138 mAb (MI15; 1:200; Dako, Glostrup, Denmark) was
performed to identify whether IgG4-positive cells were plasma
cells.
Determination of serum IgG4
Levels of serum IgG4 in a limited number of patients (n ¼ 17)
were determined using IgG4 Human ELISA kit (Thermo Fisher
Scientific, Waltham, MA) according to the manufacturer's
instructions.
Statistical analysis
Values are given as the median. The nonparametric
ManneWhitney U test was used to compare data between groups,
and Wilcoxon's signed rank test was used to analyze data within
each group. A KruskaleWallis test followed by a Dunn test was used
for multiple comparisons. Correlation analyses were performed
using Spearman's rank correlation. Statistical analyses were per-
formed with GraphPad Prism 6 software (GraphPad software, Inc.,
La Jolla, CA). Receiver operating characteristics (ROC) analyses were
performed to determine the cut-off values for IgG4-positive cells. P-
values for sensitivity and specificity were calculated using JMP Pro
13.2 (SAS Institute Inc., Cary, NC), and logistic regression analyses
were conducted by STATA 12.1 (StataCorp, College Station, TX). P-
values less than 0.05 (two-tailed) were considered to be statistically
significant.Results
Local expression of IgG4 in nasal mucosae
IgG4 was mainly expressed in infiltrating mononuclear cells
both in UT and NP (Fig. 1AeD). The number of IgG4-positive cells in
the UT and NP ranged from 0 to 7 (median: 0) and from 0 to 162
(median: 6), respectively, per HPF. Overall, the number of IgG4-
positive cells was significantly higher in NP than in UT
(P < 0.001; Fig. 1E). Double immunohistochemistry showed that
infiltrating IgG4-positive cells (red: cytoplastic staining) were sta-
nied by anti-CD138 mAb (brown: membrane staining) (Fig. 1F).
Comparison of IgG4-positive cells among the phenotypes of CRS
Samples were divided into six groups according to the pheno-
type of the CRS: UT from non-CRS (n ¼ 13), UT from CRSsNP
(n¼ 14), NP from non-ECRS (n¼ 27), NP frommild ECRS (n¼ 8), NP
from moderate ECRS (n ¼ 12), and NP from severe ECRS (n ¼ 10)
(Table 1). The KruskaleWallis test revealed a significant difference
in the number of infiltrating IgG4-positive cells among these
groups (P < 0.001; Fig. 2A). The Dunn test further showed that,
although the number was not different between UT from non-CRS
and UT from CRSsNP (P ¼ 0.725), the number was significantly
higher in each group of NP (non-ECRS: P ¼ 0.003; mild ECRS:
P ¼ 0.009; moderate ECRS: P ¼ 0.038; severe ECRS: P < 0.001) than
in UT from non-CRS. The highest degree of infiltration with IgG4-
positive cells was seen in NP from severe ECRS, and this pheno-
type showed significantly more infiltration than UT from CRSsNP
(P < 0.001) and NP from non-ECRS (P ¼ 0.013) and moderate ECRS
(P ¼ 0.039).
Among the 57 patients with NP, 20 were asthmatic. A signifi-
cantly higher number of IgG4-positive cells was seen in asthmatic
patients than in non-asthmatic patients (P < 0.001; Fig. 2B). The
presence of atopic status (serum IgE > 170 IU/ml) did not affect the
number of IgG4-positive cells in NP between non-atopic (n ¼ 10)
and atopic (n ¼ 10) asthmatics (P ¼ 0.630 by ManneWhitney U
test; Fig. 2C). In addition, 5 of the 57 NP patients had concomitant
AERD. A significantly higher number of IgG4-positive cells was seen
in AERD patients when compared to non-AERD patients (P ¼ 0.011;
Fig. 2D).
Pathophysiological significance of IgG4-positive cells in CRS
We next pathophysiologically characterized the degree of IgG4-
positive cells in sinonasal tissues. A significant positive correlation
was seen between the number of infiltrating IgG4-positive cells and
eosinophils in sinonasal tissues (n ¼ 84, r ¼ 0.509, P < 0.001;
Fig. 3A). The number was also significantly and positively correlated
with peripheral blood eosinophilia (n ¼ 84, r ¼ 0.445, P < 0.001;
Fig. 3B), the radiological severity of CRS (n ¼ 77, r ¼ 0.390,
P < 0.001; Fig. 3C), and the serum total IgE level (n ¼ 76, r ¼ 0.238,
P¼ 0.038; Fig. 3D). In contrast, no correlationwas seen between the
number of infiltrating IgG4-positive cells and the FEV1/FVC ratio
(n ¼ 83, r ¼ 0.036, P ¼ 0.743; Fig. 3E). Olfactory testing was
performed in CRSwNP patients complaining of a loss of smell. No
significant correlation between the degree of infiltrating IgG4-
positive cells and the results of identification threshold in ortho-
nasal T&T olfactometer testing was seen (n ¼ 51, r ¼ 0.223,
P ¼ 0.115; Fig. 3F); however, there appeared to be a positive cor-
relation between the cell number and the latent time in retronasal
intravenous olfactory testing (n ¼ 49, r ¼ 0.238, P ¼ 0.097; Fig. 3G).
Our preliminary result using 17 serum samples showed that the
levels of serum IgG4 significantly and positively correlated with the
number of infiltrating IgG4-positive cells in tissue (r ¼ 0.629,
Fig. 1. Immunohistochemical staining of IgG4 in UT (A, B) and NP (C, D) with different magnifications (A and C: 100, B and D: 400). E: Comparison of numbers of IgG4-positive
cells between UT and NP. P value was determined by ManneWhitney U test. F: Double immunohistochemistry using anti-human IgG4 mAb (red) and anti-human CD138 mAb
(brown).
T. Koyama et al. / Allergology International 68 (2019) 216e224 219P¼ 0.008). The KruskaleWallis test revealed a significant difference
in serum IgG4 levels among patients with non-ECRS, mild/moder-
ate ECRS and severe ECRS (P ¼ 0.006). The Dunn test further
showed a significant difference between mild/moderate ECRS and
severe ECRS (P ¼ 0.009).
Significance of infiltrating IgG4-positive cells on the post-operative
course in CRSwNP
Of the 57 patients with CRSwNP, 55 received a CT examination 6
month after surgery. The number of infiltrating IgG4-positive cells
was significantly and positively correlated with the post-operative
CT score (r ¼ 0.459, P < 0.001; Fig. 4A), showing a stronger corre-
lation than the pre-operative CT score. The rate of the residual CT
score (Post-operative CT score/Pre-operative CT score  100) was
also significantly and positively correlated with the number of
infiltrating IgG4-positive cells in NP (r ¼ 0.340, P ¼ 0.003; Fig. 4B).
In the evaluation of the post-operative course, a course was
considered to be good if the CT score 6 month after endoscopic
sinus surgerywas less than half of the pre-operative score; of the 55
patients evaluated, 40 (72.7%) patients showed a good post-
operative course, and 15 (27.3%) patients showed a poor post-
operative course. The number of infiltrating IgG4-positive cellswas significantly higher in the patients with a poor post-operative
course than in those with a good one (P ¼ 0.002; Fig. 4C).
Finally, we assessed the possibility of using the number of IgG4-
positive cells in NP as a biomarker for predicting the post-operative
course in patients with CRSwNP using ROC analysis. The number of
IgG4-positive cells in NP appeared to be a better diagnostic test for
predicting the post-operative course after endoscopic sinus surgery
(area under the curve (AUC): 0.769; 95% confidence interval (CI):
0.612  0.926) than the number of eosinophils in tissue (AUC:
0.512; 95% CI: 0.332  0.692) or the number of eosinophils in pe-
ripheral blood (AUC: 0.658; 95% CI: 0.493  0.823) (Fig. 5A). This
analysis showed that the best cut-off for IgG4-positive cells was
17 cells/HPF, and the corresponding sensitivity and specificity for
predicting the post-operative course was 73.3% (95% CI:
44.9  92.1) and 82.5% (95% CI: 67.2  92.7), respectively. With this
cut-off value, 11 of the 18 patients (61.1%) with more than or equal
to the cut-off value exhibited a poor post-operative course, whereas
4 of the 37 patients (10.8%) with less than the cut-off value
exhibited a poor post-operative course (P < 0.001 by the chi-square
test; Fig. 5B). Logistic regression analysis showed that the odds ratio
(OR) for a poor post-operative course was 12.96 (95% CI:
3.18  52.82), and the results essentially remained the same after
we adjusted by age and sex (OR: 17.60; 95% CI: 3.46  89.54), the
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Fig. 2. Comparison of numbers of tissue IgG4-positive cells based on phenotypes. A: Comparison among six subgroups including UT from non-CRS patients, UT from CRSsNP
patients, NP from non-ECRS patients, NP from mild, moderate and severe ECRS patients. B: Comparison between asthmatic and non-asthmatic patients. C: Comparison between
non-atopic and atopic patients with asthma. D: Comparison between AERD and non-AERD patients. P value was determined by Dunn test (A) and ManneWhitney U test (B and C). *
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T. Koyama et al. / Allergology International 68 (2019) 216e224220severity of ECRS (OR: 16.63; 95% CI: 3.14  88.21), and asthma
comorbidity (OR: 27.50, 95% CI: 2.47e306.2) (Fig. 5C).
Discussion
In the present study, we characterized IgG4-positive cells in CRS,
especially ECRS. We found that severe phenotypes of ECRS showed
the highest infiltration of IgG4-positive cells. The number of infil-
trating IgG4-positive cells was significantly and positively corre-
lated with the degree of local and blood eosinophilia, radiological
severity of CRS, and the level of serum total IgE. In addition, a high
infiltration of IgG4-positive cells in NP was associated with poor
control after surgery. Although we did not examine the role of IgG4
in the pathogenesis of ECRS, these results may provide a basis for
the diagnostic use of local IgG4-positive cells as a biomarker for not
only confirming the severity of ECRS, but also for predicting the
outcome after surgery.
IgG4 was mainly expressed in infiltrating plasma and plas-
macytoid cells in sinonasal tissues. It is well known that IgG4-
positive cells mainly infiltrate the periductal and/or fibro-
sclerotic areas of IgG4-RD lesions.14 Morphologically, the IgG4-
positive cells in sinonasal tissues also seem to be plasma cells
since the characteristic appearance of plasma cells, such as
eccentric nucleus with cartwheel-like chromatin and enriched
cytoplasm, was seen in the IgG4-positive cells, suggesting thatlocal class switching toward IgG4 was induced in sinonasal tis-
sues.22 In addition, infiltrating IgG4-positive cells expressed
CD138 in double immunohistochemistry, confirming that IgG4-
positive cells were plasma cells.
The number of IgG4-positive cells was significantly higher in NP
than in UT, especially those from non-CRS patients. Although
several endotypes and regional diversity do exist, the general in-
flammatory profiles of CRS have been characterized. In general,
CRSsNP show neutrophil infiltration with upregulation of non-type
2 cytokines, such as IL-6, IL-8, and IFN-g, whereas CRSwNP show
eosinophil infiltration with upregulation of type 2 cytokines, such
as IL-4, IL-5, and IL-13.23e25 Because IL-4 and IL-13 are crucial fac-
tors for inducing isotype switching to IgG4, the present findings
suggest that a microenvironment favoring type 2 inflammation
induces class switching toward IgG4 and/or the infiltration of IgG4-
positive cells in NP.6 This is supported by the result that no sig-
nificant difference in the number of infiltrating IgG4-positive cells
was found between UT from non-CRS and CRSsNP patients.
Severe phenotype of ECRS showed an augmented infiltration of
IgG4-positive cells into NP than other phenotypes in CRSwNP. On
the other hand, no significant difference in radiological severity
determined by the LundeMackay system was seen among the
phenotypes (Table 1: P ¼ 0.522 by KruskaleWallis test), suggesting
that IgG4-positive cells in NP are phenotype-specific augmentation
but not comparative increase.
Fig. 3. Relationship between the numbers of tissue IgG4-positive cells and pathophysiological characterizations of CRS including tissue eosinophilia (A), blood eosinophilia (B), pre-
operative CT score of CRS (C), serum total IgE levels (D), FEV1/FVC ratio (E), identification threshold in orthonasal T&T olfactometry testing (F), and latent time in retronasal
intravenous olfactory testing (G).
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number of infiltrating IgG4-positive cells in sinonasal tissues and
the level of serum total IgE. In the past, we failed to find any as-
sociation between the level of serum total IgE and the local levels ofinflammatory molecules, including prostaglandin D2 synthase,
prostaglandin E2 synthases, IL-17, IL-18, and IL-22.26e29 The present
study is the first to report a significant correlation, and this corre-
lation may reflect a similarity to class switching toward IgE and
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Fig. 4. Characterization of IgG4-positive cells in post-operative course after endoscopic
sinus surgery. Relationship between the numbers of tissue IgG4-positive cells and CT
score 6 months after surgery (A) and rate of residual CT score (B). C: Comparison of
numbers of IgG4-positive cells between well-controlled and poor controlled patients
after surgery. P value was determined by ManneWhitney U test.
T. Koyama et al. / Allergology International 68 (2019) 216e224222IgG4.6 IgG4 levels in sinus tissue may be associated with tissue IgE
rather than serum IgE. Investigation to determine a correlation
between local numbers of IgG4-positive cells and IgE-positive cells
in currently under the way.
A positive correlation was also found between the number of
infiltrating IgG4-positive cells and the degree of local and blood
eosinophilia. However, this finding is not consistent with a previous
report that found no significant difference in the degree of local
eosinophilia between CRS patients with high IgG4 (more than 10
positive cells/HPF and a ratio of IgG4- to IgG-positive cells of >40%)
and low IgG4 infiltration.18 This discrepancymay be due to different
subject populations and/or different evaluation criteria. In our case,non-CRS patients were included in order to investigate the corre-
lation in sinonasal tissue. Indeed, whenwe excluded the cases with
non-CRS, the correlation became weaker (n ¼ 57, r ¼ 0.254,
P ¼ 0.056 by Spearman rank correlation). However, when we
divided CRS patients into high IgG4 (>10 positive cells/HPF) and
low IgG4 (10 positive cells/HPF) groups based on the criterion set
by Ohno et al., the high IgG4 group showed significantly more se-
vere eosinophilia both in tissue (P ¼ 0.014 by the ManneWhitney
test) and peripheral blood (P < 0.001) than the low IgG4 group.18
CRSwNP patients often have comorbid asthma and AERD.19
Asthmatic patients show significantly higher infiltration of IgG4-
positive cells than non-asthmatic patients. However, the role of
IgG4 in the pathogenesis of asthma remains unclear. Allergen-
specific immunotherapy for allergic asthma induces allergen-
specific IgG4 production, and IgG4 may act as a blocking antibody
that prevents the activation and degranulation of mast cells and
basophils by competing with the allergen binding of sIgE bound to
Fcε receptors on these effector cells.30 In addition, AERD patients
also show significantly higher infiltration of IgG4-positive cells
than non-AERD patients. A recent report analyzing 12,323 patients
who had undergone IgG subclass testing found isolated elevation of
serum IgG4 in patients with AERD (P ¼ 0.017), nasal polyposis
(P ¼ 0.020), eosinophilia (P ¼ 0.038), and celiac disease
(P ¼ 0.020).31 A higher, albeit not significant, expression of IL-13
was observed in NP from ARED patients as compared with non-
AERD patients.32 In addition, enhanced expression of IL-4 mRNA
was seen in peripheral blood mononuclear cells in response to
aspirin, especially in AERD patients.33 Therefore, the higher
expression of IgG4-positive cells in AERD patients may reflect the
hypersensitivity to NSAIDs that induces type 2 cytokines, including
IL-4 and IL-13.
The number of IgG4-positive cells was correlated with post-
operative CT score which was stronger than pre-operative CT
score. This suggests that IgG4-positive cells contribute to persistent
sinus inflammation especially after surgery. When we set 17 cells/
HPF as a cut-off level, poor post-operative control could be pre-
dicted at 73.3% sensitivity and 82.5% specificity. Biomarkers for
predicting treatment outcomes in CRSwNP have been proposed,
including eosinophilia in UT, blood basophil counts and rates, the
levels of serum periostin, and the levels of staphylococcal
enterotoxin-specific IgE in serum and tissues.34e36 The present
results suggest that tissue expression of IgG4 is an additional
biomarker reflecting the severity and post-operative course of
CRSwNP, especially ECRS. We previously reported that the numbers
of eosinophilis in tissue was an important factor for predicting
recurrence of NP after surgery.1 In the present study, the number
had little prognostic value (AUC: 0.512). We think that this incon-
sistency is due to different endpoint (CT findings versus recurrence
of NP at inspection).
Interestingly, our preliminary result demonstrated a significant
and positive correlation between the numbers of infiltrating IgG4-
positive cells in tissues and serum levels of IgG4, suggesting that
the serum IgG4 level is also associated with the severity in ECRS.
Future study with large numbers of samples is required to confirm
this phenomenon. In addition, it is important to determinewhether
IgG4 expressed in sinus tissue is antigen-specific or polyclonal in
the future. A recent case study showed that IgG4 specific for des-
moglein 3, an autoantigen of Pemphigus vulgaris, was detected in
nasal and paranasal mucosa in a patient of refractory CRS with
IgG4-RD.37
In conclusion, we showed evidence that the local expression of
IgG4 is associated with disease severity and treatment outcome in
CRS, especially ECRS. In particular, the degree of expression corre-
lated with the degree of not only local eosinophilia, but also the
serum total IgE level, suggesting that IgG4 expression reflects high
Fig. 5. ROC analysis to predict post-operative course in CRSwNP. A: ROC curve for the number of IgG4-positive cells in tissue (blue), blood the number of eosinophils in peripheral
blood (green) and the number of eosinophils in tissue (red) for distinguishing subjects with well and poor course after surgery. B: Comparison of numbers of well and poor course
patients based on the cut-off value (17 cells/HPF) of IgG4-positive cells. P value was determined by Chi-square test. C: Logistic regression results using the cut-off value of IgG4-
positive cells (17 cells/HPF). Model 1: crude. Model 2: adjusted by age (continuous) and sex (female vs male; reference). Model 3: adjusted by age, sex, and severity of ECRS (non
ECRS: 0, mild ECRS: 1, moderate ECRS: 2, severe ECRS: 3). Model 4: comorbid asthma. Odds ratios [95% confidential interval] for poor course patients after surgery were shown.
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T. Koyama et al. / Allergology International 68 (2019) 216e224224type 2 inflammation. In contrast, although the present study did
not include patients with IgG4-RD, the induction of IgG4 class
switching may have regional diversity because IgG4-RD, one of the
best characterized diseases in which IgG4 is involved, is more
frequently seen in Asia, including Japan, than in other regions.38
Therefore, ECRS may share a similar immune reaction as IgG4-RD,
and future study is required to determine whether the findings
seen in this investigation are reproducible in other regions outside
of Japan.24
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